SMAD4 and ovarian carcinoma: Thus, this cell line is also an appropriate model system for carrying out genome-wide mapping of SMAD4 target genes and identifying the deregulated TGFβ/SMAD4 target genes and pathways implicated in ovarian cancer patients.